Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ProPath is a premier pathology-led provider of diagnostic services and a specialized contract research organization (CRO) serving the biopharmaceutical industry. The company offers a comprehensive range of anatomical and molecular pathology services, including subspecialty expertise in oncology, dermatology, and hematopathology. ProPath's CRO division focuses on supporting drug development through advanced techniques such as immunohistochemistry (IHC) assay development, spatial biology, and digital pathology. Following its acquisition by Sonic Healthcare in 2021, ProPath continues to operate as a key component of a global diagnostic network, providing high-quality tissue-based research and clinical diagnostics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ProPath Services.